[Responsiveness of well-differentiated PanNET G3 to platinum-based chemotherapy: a case report]

Nihon Shokakibyo Gakkai Zasshi. 2019;116(11):952-959. doi: 10.11405/nisshoshi.116.952.
[Article in Japanese]

Abstract

According to the 2017 WHO classification (4th version), PanNEC G3 was subdivided into two groups:well-differentiated PanNET G3 and poorly differentiated PanNEC. Considering the insufficient number of case reports, appropriate chemotherapy for the new category PanNET G3 remains unknown. Here, we report a case of PanNET G3 that responded to platinum-based chemotherapy.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Neoplasm Grading
  • Neuroendocrine Tumors
  • Pancreatic Neoplasms
  • Platinum*

Substances

  • Antineoplastic Agents
  • Platinum